ARTICLE | Company News
Genaissance, Otsuka deal
September 26, 2005 7:00 AM UTC
The companies partnered to identify genetic markers related to drug response using GNSC's HAP Technology. The companies will co-own resulting IP, with each company eligible for royalties from the othe...